Across-sectional survey on medication-related osteonecrosis of the jaws' knowledge and awareness in a sample of dental society.
Medication-related osteonecrosis of the jaws (MRONJ) is a prominent complication and growing problem related to the oral and maxillofacial region due to antiresorptive and antiangiogenic agents. Awareness about MRONJ is crucial for all dental practitioners identify 'at risk' patients for appropriate advice and management. This cross-sectional survey aimed to appraise MRONJ awareness and knowledge among dentists. A questionnaire-based survey was carried out through one hundred and seventy eight dentist who recruited in three groups; the first group comprised 113 general dental practitioners (GDP), 33 dental radiologist (DR) included in the second, and 32 oral and maxillofacial surgeon (OMS) in the third group. MRONJ awareness was evaluated by asking all respondents a question of "Did you heard about MRONJ? In addition, the detailed knowledge on the subject in question were addressed through fourteen, nine, and three questions for OMSs, DRs, and GDPs respectively. A significant difference were existed among groups with a rate of MRONJ's awareness of 33.6%, 48.5%, and 84.4% for GDPs, DRs, and OMSs respectively. Concerning MRONJ knowledge, significantly highest rates seen in OMSs set with 48.55%. In contrast, the average scores of DRs were 30.64%, and the GDPs group recorded the least value with 16.67%. Strengthen the MRONJ awareness and knowledge among general dentists and dental specialists are essential to identify 'at risk' patients for appropriate advice and management.